Emerging novel treatment strategies for diabetic eye diseases

Current Diabetes Reviews

Volumn 6, Issue 1, 2010, Pages 35-41

  Osanai, Makoto ^a   Nishikiori, Nami ^b   Lee, Gang Hong ^a   Sawada, Norimasa ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood retinal barrier; Cataract; Diabetes; Retinoic acid; Retinopathy; Tight junction

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ALITRETINOIN; BEVACIZUMAB; CALPAIN; CALPASTATIN; CYTOKINE; EYE DROPS; PROTEINASE; RETINOIC ACID; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CAPILLARY ENDOTHELIUM; CATARACT; CLINICAL TRIAL; DEREGULATION; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; ENZYME ACTIVITY; EYE DISEASE; GASTROINTESTINAL HEMORRHAGE; GLIA CELL; HEART INFARCTION; HOMEOSTASIS; HUMAN; LASER COAGULATION; LENS EPITHELIUM; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA CAPILLARY; REVIEW; RISK; STROKE; THROMBOEMBOLISM; TIGHT JUNCTION; VISUAL ACUITY;

CAPILLARIES; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; RETINA; RETINAL GANGLION CELLS; TIGHT JUNCTIONS;

EID: 77950839576     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339910790442619     Document Type: Review

References (29)

1. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.
2. Tsukita S, Furuse M, Itoh M. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol 1999; 11: 628-633
3. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293
4. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003; 4: 225-236
5. Osanai, M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 2006; 66: 9125-9133
6. Sawada N, Murata M, Kikuchi K, et al. Tight junctions and human diseases. Med Electron Microsc 2003; 36:147-156
7. Igarashi Y, Utsumi H, Chiba H, et al. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun 1999; 261:108-112
8. Igarashi Y, Chiba H, Utsumi H, et al. Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Funct 2000; 25: 237-241
9. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-1487
10. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92: 905-909
11. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996; 74: 819-825
12. Ng EW, Shima DT, Calias P, Cunningham ET, Guyer DR, Jr, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 2006; 5: 123-132
13. Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2004; 15: 508-518
14. Arevalo JF, Garcia-Amaris RA. Intravitreal bevacizumab for diabetic retinopathy. Curr Diabetes Rev 2009; 5: 39-46.
15. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-1132
16. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994; 266: 1062-1064
17. Miyajima H, Osanai M, Chiba H, et al. Glyceraldehyde-derived advanced glycation end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes. Biochem Biophys Res Commun 2005; 330: 361-366
18. Utsumi H, Chiba H, Kamimura Y, et al. Expression of GFRalpha1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am J Physiol Cell Physiol 2000; 279: 361-368
19. Mangelsdorf DJ, Umesono K, Evans RM. The retinoids: biology, chemistry, and medicine. In: Sporn MB, Roberts AB, Goodman DS. Eds. New York: Raven Press 1994: pp. 314-349
20. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 1995; 83: 859-869
21. Thang SH, Kobayashi M, Matsuoka I. Regulation of glial cell line-derived neurotrophic factor responsiveness in developing rat sympathetic neurons by retinoic acid and bone morphogenetic protein-2. J Neurosci 2000; 20: 2917-2925
22. Nishikiori, N, Osanai M, Chiba H, et al. Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 2007; 56: 1333-1340
23. Nishikiori N, Mitamura Y, Tashimo A, et al. Glial cell line-derived neurotrophic factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 2005; 28: 2588.
24. Nishikiori N, Osanai M, Chiba H, Kojima T, Ohguro H, Sawada N. Inhibitory effects of retinoic acid receptor alpha stimulants on murine cataractogenesis through suppression of deregulated calpains. Invest Ophthalmol Vis Sci 2007; 48: 2224-2229
25. Zatz M, Starling A. Calpains and disease. N Engl J Med 2005; 352: 2413-2423
26. Biswas S, Harris F, Dennison S, Singh JP, Phoenix D. Calpains: enzymes of vision? Med Sci Monit 2005; 11: 301-310
27. Biswas S, Harris F, Singh J, Phoenix DA. The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017. Mol Cell Biochem 2004; 261: 169-173
28. Biswas S, Harris F, Dennison S, Singh J, Phoenix DA. Calpains: targets of cataract prevention? Trends Mol Med 2004; 10: 78-84.
29. Lin D, Barnett M, Grauer L. Expression of superoxide dismutase in whole lens prevents cataract formation. Mol Vis 2005; 11: 853-858